A recent survey found roughly three million Canadians are taking GLP-1 medications like Ozempic and Mounjaro. The drugs can reduce appetite and cravings, and could also affect the body’s fat and muscle stores. Jennifer Brown, director of program innovation at Obesity Canada and a registered dietitian, says people on GLP-1 drugs may need to be more intentional about what they eat — from protein and micronutrients to fibre and fluids.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.